X0508 4 2025-10-06 0001635088 Roivant Sciences Ltd. ROIV 0001801917 Venker Eric C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM true President & Immunovant CEO true Common Shares 2025-10-06 4 M 0 127355 15.85 A 1632314 D Common Shares 2025-10-06 4 M 0 24900 7.45 A 1657214 D Common Shares 2025-10-06 4 M 0 19141 3.85 A 1676355 D Common Shares 2025-10-06 4 S 0 171396 16.34 D 1504959 D Common Shares 2025-10-07 4 M 0 67171 15.85 A 1572130 D Common Shares 2025-10-07 4 M 0 107131 7.45 A 1679261 D Common Shares 2025-10-07 4 M 0 180859 3.85 A 1860120 D Common Shares 2025-10-07 4 S 0 355161 16.15 D 1504959 D Common Shares 2025-10-08 4 M 0 10307 15.85 A 1515266 D Common Shares 2025-10-08 4 M 0 128295 7.45 A 1643561 D Common Shares 2025-10-08 4 S 0 138602 16.2 D 1504959 D Stock Option (Right to Buy) 15.85 2025-10-06 4 M 0 127355 0 D 2026-03-31 Common Stock 127355 1054528 D Stock Option (Right to Buy) 7.45 2025-10-06 4 M 0 24900 0 D 2027-11-20 Common Stock 24900 235426 D Stock Option (Right to Buy) 3.85 2025-10-06 4 M 0 19141 0 D 2032-04-19 Common Stock 19141 6457382 D Stock Option (Right to Buy) 15.85 2025-10-07 4 M 0 67171 0 D 2026-03-31 Common Stock 67171 987357 D Stock Option (Right to Buy) 7.45 2025-10-07 4 M 0 107131 0 D 2027-11-20 Common Stock 107131 128295 D Stock Option (Right to Buy) 3.85 2025-10-07 4 M 0 180859 0 D 2032-04-19 Common Stock 180859 6276523 D Stock Option (Right to Buy) 15.85 2025-10-08 4 M 0 10307 0 D 2026-03-31 Common Stock 10307 977050 D Stock Option (Right to Buy) 7.45 2025-10-08 4 M 0 128295 0 D 2027-11-20 Common Stock 128295 0 D The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025. Award of stock options to purchase Common Shares with a vesting commencement date of December 27, 2019. These options are fully vested. Award of stock options to purchase Common Shares with a vesting commencement date of October 16, 2017. These options are fully vested. Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation). By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker 2025-10-08